StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
CLIOINFO.BO$9.39+0.97%
Fair $9.39+0.0%

CLIOINFO.BO

Clio Infotech Limited

Technology / Information Technology ServicesBSE

$9.39

+0.09 (+0.97%)

Fairly Valued+0.0%Fair Value $9.39Fund rank 27/100 · Data gapFallback financials|
SA 51/C
F-Score: 5/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $11.4M · quality 45.3/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

51/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 4.0%, below the 5% threshold
Thesis & Journal · CLIOINFO.BOLocal privado en este navegador · Clio Infotech Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$103M

P/E

15.7x

↓

EV/EBITDA

37.7x

↑

ROE

4.0%

↓

Gross Margin

33.7%

↑

Debt/Equity

1.01

↑
52-Week Range$9
$4$11

TradingView lightweight chart

CLIOINFO.BO price, volumen y niveles de valoración

Último $9.390Periodo +31.0%
Fair value: $9.390

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+436.7%

FCF CAGR

—

FCF margin

86.9%

FCF / Net income

3.73x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $28.4M · net income $6.6M · FCF $24.7M

2023-FY → 2026-FY

Gross margin

33.7%+2660.4% pts

Operating margin

19.8%+3001.8% pts

Net margin

23.3%+1661.3% pts

FCF margin

86.9%+85545.0% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$28.4M$28.4M$1.5M$1.5M$184000.00
Net Income$6.6M$6.6M$571000.00$199000.00$-3.0M
EBITDA$5.7M$5.7M$-709000.00$-1.5M$-3.0M
EPS——0.050.02-0.27
Gross Margin33.7%33.7%82.7%73.3%-2626.6%
Operating Margin19.8%19.8%-48.5%-101.4%-2982.1%
Net Margin23.3%23.3%39.1%13.7%-1638.0%
Balance Sheet
Debt/Equity1.011.010.610.440.53
Current Ratio39.0439.04———
Cash Flow
Free Cash Flow$24.7M$24.7M$-3.9M$11.4M$-157.2M
Returns
ROE4.0%4.0%0.5%0.2%-2.9%
Valuation
P/E15.6515.65104.00——
EV/EBITDA37.6637.66———
P/B0.620.620.57——
Growth & Yield
Revenue Growth1847.1%1847.1%0.4%690.8%—
EPS Growth——150.0%107.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +52.9%

Total return

+52.9%

Start / end P/E

n/dx → n/dx

EPS bridge

0.05 → n/d

Residual

+52.9%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+52.9%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.